Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0U2WO
|
|||
| Former ID |
DIB013212
|
|||
| Drug Name |
ONO-2231
|
|||
| Synonyms |
ONO-1924H; PARP inhibitor (intravenous, stroke), ONO; Poly ADP ribose polymerase inhibitors (intravenous formulation, stroke), ONO
Click to Show/Hide
|
|||
| Indication | Cerebrovascular ischaemia [ICD-11: 8B1Z; ICD-10: I67.8; ICD-9: 434.91] | Discontinued in Phase 1 | [1] | |
| Company |
Ono Pharmaceutical Co Ltd
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Poly [ADP-ribose] polymerase (PARP) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022742) | |||
| REF 2 | Company report (ONO PHARMACEUTICAL) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.